ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Figure 1Loading Img

Decreased Levels of Tobacco-Specific N-Nitrosamines in Moist Snuff on the Swedish Market

View Author Information
Swedish National Food Administration, Box 622, SE-751 26 Uppsala, Sweden
Cite this: J. Agric. Food Chem. 2004, 52, 16, 5085–5088
Publication Date (Web):July 8, 2004
Copyright © 2004 American Chemical Society

    Article Views





    Other access options


    Moist snuff, or snus, on the Swedish market in 2001 and 2002 was analyzed for tobacco-specific N-nitrosamines (TSNAs) using a recently developed LC-MS/MS method. All samples of moist snuff analyzed were found to contain detectable levels of N‘-nitrosonornicotine (NNN), N‘-nitrosoanatabine (NAT), N‘-nitrosoanabasine (NAB), and 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). In the survey in 2001, all samples except for one were produced by Swedish Match (n = 14), which is the dominating manufacturer on the Swedish snuff market. In the survey in 2002, samples from both Swedish Match (n = 7) and seven smaller manufacturers (n = 20) were analyzed. Total TSNA levels of between 0.15 and 3.0 μg/g wet weight were found. In the survey in 2001 and 2002, the mean level of the total TSNA content in moist snuff was 1.1 μg/g (n = 14) and 1.0 μg/g (n = 27), respectively. The result of the survey shows that the level of TSNAs in moist snuff on the Swedish market has been greatly reduced since the middle of the 1980s. Clearly, efforts have been made by the manufacturers to reduce the level of TSNAs in snuff.

    Keywords: Tobacco; moist snuff; snus; N-nitrosamines; TSNA

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.


     To whom correspondence should be addressed. Tel:  +46 18 17 55 00; fax:  +46 18 10 58 48; e-mail:  [email protected].

     4 rue Saint Laurent, 60000 Beauvais, France.

    Cited By

    This article is cited by 60 publications.

    1. Jeffrey R. Ammann, Katherine S. Lovejoy, Matthew J. Walters, and Matthew R. Holman . A Survey of N′-Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015. Journal of Agricultural and Food Chemistry 2016, 64 (21) , 4400-4406.
    2. Irina Stepanov, Peter W. Villalta, Aleksandar Knezevich, Joni Jensen, Dorothy Hatsukami and Stephen S. Hecht. Analysis of 23 Polycyclic Aromatic Hydrocarbons in Smokeless Tobacco by Gas Chromatography−Mass Spectrometry. Chemical Research in Toxicology 2010, 23 (1) , 66-73.
    3. Håkon Valen, Rune Becher, Gunn Elisabeth Vist, Jørn Andreas Holme, Ibrahimu Mdala, Ida‐Kristin Ørjasæter Elvsaas, Jan Alexander, Vigdis Underland, Bendik Christian Brinchmann, Tom Kristian Grimsrud. A systematic review of cancer risk among users of smokeless tobacco (Swedish snus) exclusively, compared with no use of tobacco. International Journal of Cancer 2023, 153 (12) , 1942-1953.
    4. Jessica Edstorp, Yuxia Wei, Emma Ahlqvist, Lars Alfredsson, Valdemar Grill, Leif Groop, Bahareh Rasouli, Elin P. Sørgjerd, Per M. Thorsby, Tiinamaija Tuomi, Bjørn O. Åsvold, Sofia Carlsson. Smoking, use of smokeless tobacco, HLA genotypes and incidence of latent autoimmune diabetes in adults. Diabetologia 2023, 66 (1) , 70-81.
    5. Sofia Carlsson. Lifestyle or Environmental Influences and Their Interaction With Genetic Susceptibility on the Risk of LADA. Frontiers in Endocrinology 2022, 13
    6. Salma El-Amin, Jaana M. Kinnunen, Arja Rimpelä. Adolescents’ Perceptions of Harmfulness of Tobacco and Tobacco-like Products in Finland. International Journal of Environmental Research and Public Health 2022, 19 (3) , 1485.
    7. Benjamin W Chaffee, Peyton Jacob, Elizabeth T Couch, Neal L Benowitz. Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States. Nicotine & Tobacco Research 2020, 22 (10) , 1764-1771.
    8. David Araneda, Tellervo Korhonen, Tiina Laatikainen, Ari Haukkala, Richard J. Rose, Jaakko Kaprio. Association of snus experimentation in late adolescence with daily cigarette smoking in early adulthood: A longitudinal study among Finnish men. Scandinavian Journal of Public Health 2020, 48 (6) , 638-645.
    9. Serban C. Moldoveanu, Marlene Adams, Frank K. St.Charles. Variations of TSNA Levels in Tobaccos Upon Heating at Moderate Temperatures. Contributions to Tobacco & Nicotine Research 2020, 29 (2) , 84-96.
    10. R Gupta, S Gupta, S Sharma, D N Sinha, R Mehrotra. Association of smokeless tobacco and cerebrovascular accident: a systematic review and meta-analysis of global data. Journal of Public Health 2020, 42 (2) , e150-e157.
    11. Singaraj Ranjani, Jaganathan Kowshik, Josephraj Sophia, Ramesh Nivetha, Abdul B. Baba, Veeran Veeravarmal, Gordana Joksić, Lars E. Rutqvist, Robert Nilsson, Siddavaram Nagini. Activation of PI3K/Akt/NF-kB Signaling Mediates Swedish Snus Induced Proliferation and Apoptosis Evasion in the Rat Forestomach: Modulation by Blueberry. Anti-Cancer Agents in Medicinal Chemistry 2020, 20 (1) , 59-69.
    12. Tameka S. Lawler, Stephen B. Stanfill, Hang T. Tran, Grace E. Lee, Patrick X. Chen, J. Brett Kimbrell, Joseph G. Lisko, Carolina Fernandez, Samuel P. Caudill, B. Rey deCastro, Clifford H. Watson, . Chemical analysis of snus products from the United States and northern Europe. PLOS ONE 2020, 15 (1) , e0227837.
    13. Irina Stepanov, Dorothy K. Hatsukami. Chemical characterization of smokeless tobacco products and relevant exposures in users. 2020, 121-150.
    14. Jasmine Kaur, Arun Sharma, Amit Kumar, Deeksha Bhartiya, Dhirendra Narain Sinha, Suchitra Kumari, Ruchika Gupta, Ravi Mehrotra, Harpreet Singh. SLTChemDB: A database of chemical compounds present in Smokeless tobacco products. Scientific Reports 2019, 9 (1)
    15. Gordana Joksić, Lars Erik Rutqvist, Mileva Mićić, Jelena Filipović Tričković, Robert Nilsson. Factors effecting the induction of rat forestomach hyperplasia induced by Swedish oral smokeless tobacco (snus). Regulatory Toxicology and Pharmacology 2019, 104 , 21-28.
    16. Alpana K. Gupta, Sonam Tulsyan, Mausumi Bharadwaj, Ravi Mehrotra. Grass roots approach to control levels of carcinogenic nitrosamines, NNN and NNK in smokeless tobacco products. Food and Chemical Toxicology 2019, 124 , 359-366.
    17. Leonie R. Price, Javier Martinez. Biological effects of nicotine exposure: A narrative review of the scientific literature. F1000Research 2019, 8 , 1586.
    18. Leonie R. Price, Javier Martinez. Cardiovascular, carcinogenic and reproductive effects of nicotine exposure: A narrative review of the scientific literature. F1000Research 2019, 8 , 1586.
    19. Anneli Sundkvist, Robin Myte, Stina Bodén, Stefan Enroth, Ulf Gyllensten, Sophia Harlid, Bethany van Guelpen. Targeted plasma proteomics identifies a novel, robust association between cornulin and Swedish moist snuff. Scientific Reports 2018, 8 (1)
    20. Adam J. Gushgari, Rolf U. Halden. Critical review of major sources of human exposure to N-nitrosamines. Chemosphere 2018, 210 , 1124-1136.
    21. Anatole Abaquesne de Parfourus. “Breaking through the Foul and Ugly Mists of Vapours”— Regulation of Alternative Tobacco and Related Products by the New TPD and Exercise of EU Competence. German Law Journal 2018, 19 (6) , 1291-1348.
    22. Robert Nilsson. Use of rodent data for cancer risk assessment of smokeless tobacco in the regulatory context. Regulatory Toxicology and Pharmacology 2017, 88 , 338-348.
    23. Min Chen, Leijun Wang, Huizhong Dong, Xi Shao, Da Wu, Baizhan Liu, Xiangmin Zhang, Chaoying Chen. Quantitative method for analysis of tobacco‐specific N ‐nitrosamines in mainstream cigarette smoke by using heart‐cutting two‐dimensional liquid chromatography with tandem mass spectrometry. Journal of Separation Science 2017, 40 (9) , 1920-1927.
    24. Serban C. Moldoveanu, Jeff Zhu, Nancy Qian. Analysis of Traces of Tobacco-Specific Nitrosamines (TSNAs) in USP Grade Nicotine, E-Liquids, and Particulate Phase Generated by the Electronic Smoking Devices. Beiträge zur Tabakforschung International/Contributions to Tobacco Research 2017, 27 (6) , 86-96.
    25. S. Carlsson, T. Andersson, M. Araghi, R. Galanti, A. Lager, M. Lundberg, P. Nilsson, M. Norberg, N. L. Pedersen, Y. Trolle‐Lagerros, C. Magnusson. Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts. Journal of Internal Medicine 2017, 281 (4) , 398-406.
    26. Xingyu Liu, Jie Zhang, Limeng Wang, Bicheng Yang, Chen Zhang, Wei Liu, Jun Zhou. In vitro metabolism of N′-Nitrosonornicotine catalyzed by cytochrome P450 2A13 and its inhibition by nicotine, N′-Nitrosoanatabine and N′-Nitrosoanabasine. Chemico-Biological Interactions 2016, 260 , 263-269.
    27. Aishwarya L Vidyasagaran, Kamran Siddiqi, Mona Kanaan. Use of smokeless tobacco and risk of cardiovascular disease: A systematic review and meta-analysis. European Journal of Preventive Cardiology 2016, 23 (18) , 1970-1981.
    28. Alicia Allen, Rachel Isaksson Vogel, Ellen Meier, Amanda Anderson, Joni Jensen, Herbert H. Severson, Dorothy Hatsukami. Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers. Drug and Alcohol Dependence 2016, 168 , 8-12.
    29. Robert Nilsson, Mileva Mićić, Jelena Filipović, Ana Valenta Šobot, Dunja Drakulić, Miloš Stanojlović, Gordana Joksiċ. Inhibition by blueberries (bilberries) and extract from milk thistle of rat forestomach hyperplasia induced by oral smokeless tobacco (Swedish snus). Regulatory Toxicology and Pharmacology 2016, 76 , 94-101.
    30. Lucy Popova, Pamela M Ling. Nonsmokers’ responses to new warning labels on smokeless tobacco and electronic cigarettes: an experimental study. BMC Public Health 2014, 14 (1)
    31. Neal L. Benowitz. Emerging Nicotine Delivery Products. Implications for Public Health. Annals of the American Thoracic Society 2014, 11 (2) , 231-235.
    32. Anna Gunnerbeck, Anna-Karin Edstedt Bonamy, Anna-Karin Wikström, Fredrik Granath, Ronny Wickström, Sven Cnattingius, . Maternal Snuff Use and Smoking and the Risk of Oral Cleft Malformations - A Population-Based Cohort Study. PLoS ONE 2014, 9 (1) , e84715.
    33. , Sudhanshu Ramesh Patwardhan, Marina A. Murphy. Survey of GPs’ understanding of tobacco and nicotine products. Drugs and Alcohol Today 2013, 13 (2) , 119-150.
    34. Hyun-Ji Kim, Ho-Sang Shin. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography–tandem mass spectrometry. Journal of Chromatography A 2013, 1291 , 48-55.
    35. Lucy Popova, Pamela M. Ling. Alternative Tobacco Product Use and Smoking Cessation: A National Study. American Journal of Public Health 2013, 103 (5) , 923-930.
    36. Maria L.E. Andersson, Stefan Bergman, Maria K. Söderlin. The Effect of Snuff (Smokeless Tobacco) on Disease Activity and Function in Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 2013, 19 (1) , 14-18.
    37. Sadie Palmisano, Judith Schwartzbaum, Michaela Prochazka, David Pettersson, Tommy Bergenheim, Rut Florentzson, Henrik Harder, Tiit Mathiesen, Gunnar Nyberg, Peter Siesjö, Maria Feychting. Role of Tobacco Use in the Etiology of Acoustic Neuroma. American Journal of Epidemiology 2012, 175 (12) , 1243-1251.
    38. Christopher R. E. Coggins, Mark Ballantyne, Margareta Curvall, Lars-Erik Rutqvist. The in vitro toxicology of Swedish snus. Critical Reviews in Toxicology 2012, 42 (4) , 304-313.
    39. Coral E. Gartner, Brad Partridge. Addiction Neuroscience and Tobacco Control. 2012, 75-93.
    40. Pasquale Caponnetto, Riccardo Polosa, Cristina Russo, Carmelo Leotta, Davide Campagna. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. Journal of Medical Case Reports 2011, 5 (1)
    41. Robert Nilsson. The molecular basis for induction of human cancers by tobacco specific nitrosamines. Regulatory Toxicology and Pharmacology 2011, 60 (2) , 268-280.
    42. Peter N. Lee. Summary of the epidemiological evidence relating snus to health. Regulatory Toxicology and Pharmacology 2011, 59 (2) , 197-214.
    43. Susan A. Colilla. An epidemiologic review of smokeless tobacco health effects and harm reduction potential. Regulatory Toxicology and Pharmacology 2010, 56 (2) , 197-211.
    44. T. L. Root, E. M. Pisetsky, L. Thornton, P. Lichtenstein, N. L. Pedersen, C. M. Bulik. Patterns of co-morbidity of eating disorders and substance use in Swedish females. Psychological Medicine 2010, 40 (1) , 105-115.
    45. Michael D. Johnson, Jodi Schilz, Mirjana V. Djordjevic, Jerry R. Rice, Peter G. Shields. Evaluation of In vitro Assays for Assessing the Toxicity of Cigarette Smoke and Smokeless Tobacco. Cancer Epidemiology, Biomarkers & Prevention 2009, 18 (12) , 3263-3304.
    46. H Klus, M Kunze, S Koenig, E Poeschl. Smokeless Tobacco - An Overview. Beiträge zur Tabakforschung International/Contributions to Tobacco Research 2009, 23 (5) , 248-276.
    47. David S. Timberlake. Are smokers receptive to using smokeless tobacco as a substitute?. Preventive Medicine 2009, 49 (2-3) , 229-232.
    48. Gunnar Lundqvist, Herbert Sandström, Ann Öhman, Lars Weinehall. Patterns of tobacco use: A 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population. Scandinavian Journal of Public Health 2009, 37 (2) , 161-167.
    49. H. Furberg, P. Lichtenstein, N. L. Pedersen, C. M. Bulik, C. Lerman, P. F. Sullivan. Snus use and other correlates of smoking cessation in the Swedish Twin Registry. Psychological Medicine 2008, 38 (9) , 1299-1308.
    50. Ann Roosaar, Anna L.V. Johansson, Gunilla Sandborgh‐Englund, Tony Axéll, Olof Nyrén. Cancer and mortality among users and nonusers of snus. International Journal of Cancer 2008, 123 (1) , 168-173.
    51. Coral E Gartner, Wayne D Hall. Should Australia lift its ban on low nitrosamine smokeless tobacco products?. Medical Journal of Australia 2008, 188 (1) , 44-46.
    52. Dorothy K. Hatsukami, Jon O. Ebbert, Rachel M. Feuer, Irina Stepanov, Stephen S. Hecht. Changing Smokeless Tobacco Products. American Journal of Preventive Medicine 2007, 33 (6) , S368-S378.
    53. M. McKee, A. Gilmore. Commentary: Smokeless tobacco: seeing the whole picture. International Journal of Epidemiology 2007, 36 (4) , 805-808.
    54. Jonathan Foulds, Lynn Kozlowski. Snus—what should the public-health response be?. The Lancet 2007, 369 (9578) , 1976-1978.
    55. Helena Furberg, Paul Lichtenstein, Nancy L. Pedersen, Cynthia Bulik, Patrick F. Sullivan. Cigarettes and oral snuff use in Sweden: prevalence and transitions. Addiction 2006, 101 (10) , 1509-1515.
    56. S. Jane Henley, Michael J. Thun. Response to: Foulds J and Ramstrom L Letter Regarding “Causal Effects of Smokeless Tobacco on Mortality in CPS-I and CPS-II”. Cancer Causes & Control 2006, 17 (6) , 857-858.
    57. Irina Stepanov, Joni Jensen, Dorothy Hatsukami, Stephen Hecht. Tobacco‐specific nitrosamines in new tobacco products. Nicotine & Tobacco Research 2006, 8 (2) , 309-313.
    58. Kerstin Rosenquist, Johan Wennerberg, Elsy-Britt Schildt, Anna Bladström, Bengt Göran Hansson, Gunilla Andersson. Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Oto-Laryngologica 2005, 125 (9) , 991-998.
    59. H. Daniel Roth, Adam B. Roth, Xiao Liu. Health Risks of Smoking Compared to Swedish Snus. Inhalation Toxicology 2005, 17 (13) , 741-748.
    60. Gail Topping. Smokeless tobacco use is associated with a substantial risk of oral cancers in India. Evidence-Based Dentistry 2004, 5 (3) , 79-79.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect